Coronary calcium scores are highly utilized to spot hidden cardiovascular risk, and  new research suggests that timing is important. Today’s conversation between Maeson Latsko, PhD and Millicent Kee, MSN, FNP-BC will break down how timing plays a role in proper assessment of calcium scoring, and how biomarker testing such as Apolipoprotein B, Myeloperoxidase, Lp-PLA2, and hs-CRP can be paired with physiological assessments like calcium scoring to help guide patient care, especially when calcium scoring doesn’t tell the full story. This episode will Review what calcium scoring is (1:30) Discuss how timing of calcium scoring can influence interpretation of results (3:15) Explain why statin-treated patients should not monitor their risk using a calcium score (7:00) Discuss ways biomarker testing such as ApoB, MPO, Lp-pla2, and hs-CRP can reveal hidden risk outside of the window indicated for calcium scoring (11:30; 14:30)   To learn more, please review the additional resources below for information on our cardiovascular, metabolic, endocrine, and wellness offerings as well as educational resources and insights from our team of experts. At Quest Diagnostics, we are committed to providing you with results and insights to support your clinical decisions.   Date: 9/2025 Speaker(s):  Maeson Latsko, PhD; Millicent Kee, MSN, FNP-BC Contributor(s): Maeson Latsko, PhD; Millicent Kee, MSN, FNP-BC; Trisha Winchester, PhD; Kathryn Morales, MS     Additional Resources: Apolipoprotein B | Test Detail | Quest Diagnostics hs-CRP | Test Detail | Quest Diagnostics Lp-pla2 | Test Detail | Quest Diagnostics Myeloperoxidase | Test Detail | Quest Diagnostics